IP Library Granted Patent US 11,723,711
Granted Patent B2
US 11,723,711 · App. 16/874,185 · Granted Aug 15, 2023

Power-controlled waveform in electrosurgical systems

Inventors: Kester Julian Batchelor (Mound, MN); Maureen D. Busche (Cokato, MN); Wayne Williams (Penarth, GB)
Assignee: Gyrus ACMI, Inc.
A61B18/1206A61B18/00A61B18/1233A61B18/14A61B18/1442A61B18/1445A61B2017/00017A61B2017/00115A61B2017/00132A61B2017/00154A61B2017/00194A61B2018/0063A61B2018/0072A61B2018/0075A61B2018/00648A61B2018/00654A61B2018/00666A61B2018/00678A61B2018/00702A61B2018/00708A61B2018/00714A61B2018/00755A61B2018/00761A61B2018/00767A61B2018/00779A61B2018/00791A61B2018/00827A61B2018/00875A61B2018/00886A61B2018/00898A61B2018/00928A61B2018/00994A61B2018/1467
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,723,711
App. No.
16/874,185
Granted
Aug 15, 2023
Kind
B2
Abstract

Apparatus and associated methods relate to controlling electrical power of an electrotherapeutic signal that is provided to a biological tissue engaged by an electrosurgical instrument during a medical procedure. Electrical power—a product of a voltage difference across and an electrical current conducted by the engaged biological tissue—is controlled according to a therapeutic schedule. The electrotherapeutic schedule can be reduced or terminated in response to a termination criterion being met. In some examples, the termination criterion is a current characteristic, such as, for example, a decrease in current conducted by the engaged biological tissue. In some examples, the termination criterion is a biological tissue resistance characteristic, such as, for example, an increase in the biological tissue resistance that exceeds a predetermined delta resistance value.

Claims (33)

1. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising:

a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to:

control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by monotonically increasing the electrical power as a function of resistance, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase.

2. The surgical generator of claim 1 , wherein the control circuit is configured to:

control a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan.

3. The surgical generator of claim 2 , wherein the control circuit is configured to:

monitor the voltage of the therapeutic signal; and

maintain the voltage when the voltage meets a voltage threshold.

4. The surgical generator of claim 1 , wherein the control circuit is configured to:

control the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve.

5. The surgical generator of claim 4 , wherein the pre-defined power curve includes a linear portion.

6. The surgical generator of claim 4 , wherein the pre-defined power curve includes two or more linear portions.

7. A method of delivering controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the method comprising:

generating, using an electrical-energy source electrically coupled to the instrument, the therapeutic signal; and

controlling the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by monotonically increasing modifying the electrical power as a function of resistance, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase.

8. The method of claim 7 , comprising:

controlling a voltage of the therapeutic signal provided to the biological tissue during a portion of a drying phase according to the therapeutic plan.

9. The method of claim 8 , comprising:

monitoring the voltage of the therapeutic signal; and

maintaining the voltage when the voltage meets a voltage threshold.

10. The method of claim 7 , comprising:

controlling the electrical power of the therapeutic signal provided to the biological tissue during the portion of the therapeutic phase using a pre-defined power curve.

11. The method of claim 10 , wherein the pre-defined power curve includes a linear portion.

12. The method of claim 11 , wherein the pre-defined power curve includes two or more linear portions.

13. A surgical generator configured to generate and provide controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the surgical generator comprising:

a control circuit in communication with an electrical-energy source, the electrical-energy source electrically coupled to the instrument and configured to generate the therapeutic signal, the control circuit configured to:

control the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by monotonically increasing the electrical power as a function of current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase.

14. The surgical generator of claim 13 , wherein the function of current is a function of an instantaneous measured change in current.

15. A method of delivering controlled electrical power of a therapeutic signal to biological tissue in electrical communication with an instrument, the method comprising:

generating, using an electrical-energy source electrically coupled to the instrument, the therapeutic signal; and

controlling the electrical power of the therapeutic signal provided to the biological tissue during a portion of a non-sealing therapeutic phase according to a therapeutic plan by monotonically increasing the electrical power as a function of current, wherein the electrical power decreases to a non-zero level between the non-sealing therapeutic phase and a subsequent therapeutic phase.

16. The method of claim 15 , wherein the function of current is a function of an instantaneous measured change in current.

17. The method of claim 16 , wherein the function of the instantaneous measured change in current is a linear function.

Assignments (4)
CONFIRMATORY ASSIGNMENT Recorded Dec 2, 2022
From: GYRUS MEDICAL LIMITED
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 062048/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2022
From: BATCHELOR, KESTER JULIAN
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 058792/0760 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2022
From: BUSCHE, MAUREEN D.
To: GYRUS ACMI, INC. D/B/A OLYMPUS SURGICAL TECHNOLOGIES AMERICA
Reel/Frame 058792/0988 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 27, 2022
From: WILLIAMS, WAYNE
To: GYRUS MEDICAL LIMITED
Reel/Frame 058793/0115 →
Continuity (8)
Continuation PCTUS2020031857 · May 7, 2020
Provisional Application 62905345 · Sep 24, 2019
Provisional Application 62905337 · Sep 24, 2019
Provisional Application 62905360 · Sep 24, 2019
Provisional Application 62905318 · Sep 24, 2019
Provisional Application 62905366 · Sep 24, 2019
Provisional Application 62845647 · May 9, 2019
Related Publication 20200352625A1 · Nov 12, 2020
Cited By (4)
US 12,193,721 US 12,303,183 US 12,440,262 US 12,714,489